Hit Enter to search or Esc to close
0

NMN, ergothioneine, PQQ and astaxanthin: The synergistic power of a scientific combination for a healthy lifestyle.

2025-10-30
1.1 Dose and Clinical Effectiveness
The human clinical research on NMN has made significant progress in recent years. A clinical trial conducted on elderly people over 65 years old found that daily supplementation of 250mg NMN for 12 consecutive weeks could significantly alleviate fatigue and improve physical functions, enhance insulin sensitivity, and improve metabolic functions. Another study showed that NMN also has potential in improving cardiovascular function, with significant improvement in the elasticity of the subjects' blood vessels. However, long-term large-scale human studies are still ongoing to further verify its safety and optimal dosage.
Clinical studies on ergothioneine in humans have also yielded positive results. A 12-week randomized, double-blind, placebo-controlled trial showed that daily intake of 10mg of ergothioneine significantly increased skin moisture content, reduced facial wrinkles and texture. Moreover, ergothioneine also performed well in protecting brain neurons and reducing inflammatory responses. However, due to the limited natural sources, the extraction process is difficult, the price is relatively high, and the research on oral bioavailability is still ongoing.
The human clinical studies of PQQ have shown that it has significant effects in enhancing brain cognitive functions and overall vitality. In a clinical trial targeting middle-aged and elderly people, when 20mg of PQQ was supplemented daily for 12 consecutive weeks, the cognitive function scores of the participants significantly improved, fatigue significantly decreased, and sleep quality also improved. However, the research history of PQQ in the field of anti-aging is relatively short, and the optimal dosage and long-term effects are still under exploration.
Human clinical studies on astaxanthin have shown that it has significant effects in improving skin elasticity and luster, reducing wrinkles, and enhancing the recovery ability after exercise. In a clinical trial conducted on athletes, when 12mg of astaxanthin was supplemented daily for 8 consecutive weeks, the athletes experienced a significant reduction in exercise fatigue and a shorter recovery time. Moreover, astaxanthin has positive effects on eye health, preventing macular degeneration and retinal disorders. However, the bioavailability of natural astaxanthin is relatively low, and it is usually necessary to enhance its absorption efficiency through technologies such as liposome encapsulation or esterification.
1.2 Safety Assessment
The safety of NMN has been verified in multiple short-term and medium-term clinical trials. The subjects did not experience any serious adverse reactions after supplementing with NMN. However, the long-term safety of NMN still requires further research, especially regarding its potential effects on liver function and metabolic systems. Additionally, the dosage and frequency of NMN supplementation need to be adjusted according to individual differences to ensure its safety and effectiveness.
The safety of ergothioneine has also been verified in several short-term and medium-term clinical trials. The subjects did not experience any serious adverse reactions after supplementing with ergothioneine. However, due to the limited natural sources, the difficulty in extraction, the relatively high price, and the ongoing research on the oral bioavailability, its large-scale application still requires caution. Additionally, the safety of long-term supplementation with ergothioneine still needs further study, especially regarding its potential effects on kidney function and the immune system.
The safety of PQQ has been verified in multiple short-term and medium-term clinical trials. The subjects did not experience any serious adverse reactions after supplementing with PQQ. However, the research history of PQQ in the field of anti-aging is relatively short, and its long-term safety for supplementation still requires further study, especially regarding its potential effects on liver function and metabolic systems. Additionally, the optimal dose and supplementation frequency of PQQ need to be adjusted according to individual differences to ensure its safety and effectiveness.
The safety of astaxanthin has been verified in numerous short-term and mid-term clinical trials. The subjects did not experience any serious adverse reactions after supplementing with astaxanthin. However, due to the relatively low bioavailability of natural astaxanthin, it is usually necessary to enhance its absorption efficiency through techniques such as liposome encapsulation or esterification. Therefore, its large-scale application still requires caution.

Related News